Advances in Telemedicine

Advances in Telemedicine

COVID-19 rapidly accelerated the use of telemedicine technologies and their acceptance by HCPs and patients is now well established. Favourable regulation and rising reimbursement is further seeing telehealth embedded in the healthcare ecosystem. So, where does pharma fit in? Why should pharma be interested in remote patient monitoring? What role can telemedicine play in chronic disease management? In this report experts assess the technologies that are driving change and the innovations which will shape the delivery of healthcare in the future.

Companies

Pfizer, Fitbit, GE Healthcare, Apple, Amwell, Teladoc, Validic, 23andMe, Aptar Pharma, Alpenglow Biosciences, Enhance3D Genomics, Globant, HealthTap, Medfuture, MedWand Solutions, mWell, Motto, Nonagon, Oracle Cerner, SHL Telemedicine, URAC, White Rock Medical Center


Subject synopsis
Research methodology and objectives
Experts interviewed
Key research objectives
Key insights summary
Issues and insights
The current role of telemedicine in healthcare delivery
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Applications and innovations of telemedicine
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Challenges in the development and commercialisation of telemedicine
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Future opportunities for telemedicine in healthcare delivery
Issue summary
Questions
Key insights
Supporting quotes
Intelligence exhibits
Further Reading
Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings